Page last updated: 2024-09-03

prolyl-phenylalanyl-arginine-4-nitroanilide and arginine

prolyl-phenylalanyl-arginine-4-nitroanilide has been researched along with arginine in 2 studies

Compound Research Comparison

Studies
(prolyl-phenylalanyl-arginine-4-nitroanilide)
Trials
(prolyl-phenylalanyl-arginine-4-nitroanilide)
Recent Studies (post-2010)
(prolyl-phenylalanyl-arginine-4-nitroanilide)
Studies
(arginine)
Trials
(arginine)
Recent Studies (post-2010) (arginine)
380146,3881,68811,176

Protein Interaction Comparison

ProteinTaxonomyprolyl-phenylalanyl-arginine-4-nitroanilide (IC50)arginine (IC50)
Cationic amino acid transporter 3Homo sapiens (human)283

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colman, RW; Scott, CF; Tschesche, HR; Wenzel, HR1
Kumar, A; Mikolajczyk, SD; Millar, LS; Saedi, MS1

Other Studies

2 other study(ies) available for prolyl-phenylalanyl-arginine-4-nitroanilide and arginine

ArticleYear
Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
    Blood, 1987, Volume: 69, Issue:5

    Topics: Aprotinin; Arginine; Clinical Enzyme Tests; Evaluation Studies as Topic; Factor XI; Factor XIa; Factor XII; Factor XIIa; Fibrinolysin; Humans; Kallikreins; Kinetics; Microchemistry; Oligopeptides; Peptide Fragments; Peptide Hydrolases; Structure-Activity Relationship; Thrombin

1987
Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
    The Prostate, 1998, Jan-01, Volume: 34, Issue:1

    Topics: alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha-2-Antiplasmin; Amino Acid Sequence; Animals; Antithrombin III; Arginine; Biomarkers, Tumor; Cell Line; Chromogenic Compounds; Cricetinae; Humans; Kallikreins; Male; Molecular Sequence Data; Oligopeptides; Peptides; Prostatic Neoplasms; Recombinant Fusion Proteins; Serine Proteinase Inhibitors; Serpins; Substrate Specificity; Tissue Kallikreins

1998